Cilazapril is an angiotensin-converting enzyme (ACE) inhibitor used for the treatment of hypertension and congestive heart failure. It helps relax blood vessels, lowering blood pressure. It is grouped under the following drug class(es): ACE Inhibitors. Its therapeutic use is listed as cardiovascular. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Inhibace, Cilazaprilum, Justor and Vascace. Its PubChem CID is 56330.
Cilazapril
| CAS No | 88768-40-5 |
|---|---|
| Molecular Formula | C22H31N3O5 |
| Molecular Weight | 417.5 g/mol |
| Synonyms | (4S,7S)-7-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-6-oxo-1,2,3,4,7,8,9,10-octahydropyridazino[1,2-a]diazepine-4-carboxylic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Cilazapril is an angiotensin-converting enzyme (ACE) inhibitor used for the treatment of hypertension and congestive heart failure. It helps relax blood vessels, lowering blood pressure.
The listed CAS number is 88768-40-5.
The listed molecular formula is C22H31N3O5.
The listed molecular weight is 417.5 g/mol.
(4S,7S)-7-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-6-oxo-1,2,3,4,7,8,9,10-octahydropyridazino[1,2-a]diazepine-4-carboxylic acid.
The source lists Inhibace, Cilazaprilum, Justor and Vascace.